U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool (DDT) Qualification Programs
  5. Clinical Outcome Assessment (COA) Qualification Program
  6. DDT COA #000017: Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease (E-RS: COPD)
  1. Clinical Outcome Assessment (COA) Qualification Program

DDT COA #000017: Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease (E-RS: COPD)

Qualified Clinical Outcome Assessments (COA)
Office Immunology and Inflammation (OII)
Division of Pulmonary, Allergy, and Critical Care (DPACC)

DDT COA Number
DDT COA #000017

Instrument Name
Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease (E-RS: COPD)

Disease/Condition
Chronic Obstructive Pulmonary Disease (COPD)

Concept of Interest
Respiratory symptoms of stable COPD

Context of Use
Adult outpatients with stable COPD

COA Type
PRO

Requestor(s)
Evidera

Contact(s)
Nancy Leidy

Qualification Date
March 10, 2016
Qualification Statement*

Qualification Supporting Information
Clinical Outcome Assessments Staff Review

*Under review prior to the passage of the 21st Century Cures Act

Back to Qualified Clinical Outcome Assessments (COA)

 
Back to Top